These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24046790)

  • 1. Egy-score predicts severe hepatic fibrosis and cirrhosis in Egyptians with chronic liver diseases: a pilot study.
    Alboraie MA; Afifi ME; Elghamry FG; Shalaby HA; Elshennawy GE; Abdelaziz AA; Shaheen MU; Abo El-Seoud AR
    Hepat Mon; 2013; 13(6):e10810. PubMed ID: 24046790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Egy-score as a noninvasive score for the assessment of hepatic fibrosis in chronic hepatitis C: a preliminary approach.
    Alboraie M; Khairy M; Elsharkawy A; Elsharkawy M; Asem N; Abo El-Seoud AR; Elghamry FG; Esmat G
    Saudi J Gastroenterol; 2014; 20(3):170-4. PubMed ID: 24976280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Hepa-index as a non-invasive biomarkers panel for assessment of hepatic fibrosis in Egyptians with chronic hepatitis C.
    Alboraie M; Schütte K; Khairy M; Elsharkawy M; Asem N; Elghamry F; Shalaby H; Esmat G; Malfertheiner P
    Saudi Med J; 2017 Nov; 38(11):1137-1142. PubMed ID: 29114703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns' index in chronic hepatitis C virus.
    Alboraie M; Khairy M; Elsharkawy M; Asem N; Elsharkawy A; Esmat G
    Hepatol Res; 2015 May; 45(5):560-70. PubMed ID: 24995544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficiency of Fib-4, Egy-score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C.
    Cordie A; Salama A; El-Sharkawy M; El-Nahaas SM; Khairy M; Elsharkawy A; Hassany M; Esmat G
    J Med Virol; 2018 Jun; 90(6):1106-1111. PubMed ID: 29476628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
    Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
    Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
    Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
    World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis.
    Aizawa N; Enomoto H; Imanishi H; Saito M; Iwata Y; Tanaka H; Ikeda N; Sakai Y; Takashima T; Iwai T; Moriwaki E; Shimomura S; Iijima H; Nakamura H; Nishiguchi S
    World J Hepatol; 2012 Jan; 4(1):11-7. PubMed ID: 22312451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study.
    Myers RP; Elkashab M; Ma M; Crotty P; Pomier-Layrargues G
    Can J Gastroenterol; 2010 Nov; 24(11):661-70. PubMed ID: 21157581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
    Adams LA; Bulsara M; Rossi E; DeBoer B; Speers D; George J; Kench J; Farrell G; McCaughan GW; Jeffrey GP
    Clin Chem; 2005 Oct; 51(10):1867-73. PubMed ID: 16055434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
    Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
    World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients.
    Toson EA; Shiha GE; Abdelgaleel AE
    Ann Hepatol; 2017 November-December,; 16(6):862-873. PubMed ID: 29055924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus.
    Lubner MG; Jones D; Said A; Kloke J; Lee S; Pickhardt PJ
    Abdom Radiol (NY); 2018 Nov; 43(11):2980-2986. PubMed ID: 29572714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection.
    El-Kamary SS; Mohamed MM; El-Raziky M; Shardell MD; Shaker OG; ElAkel WA; Esmat G
    Liver Int; 2013 Aug; 33(7):982-90. PubMed ID: 23509874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG; Senousy MA
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis.
    Attallah AM; Albannan MS; Omran MM; Zayed R; Saif S; Farid A; Hassany M; Yosry A; Omran D
    Br J Biomed Sci; 2019 Jul; 76(3):105-110. PubMed ID: 30924403
    [No Abstract]   [Full Text] [Related]  

  • 19. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
    World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
    Myers RP; Benhamou Y; Imbert-Bismut F; Thibault V; Bochet M; Charlotte F; Ratziu V; Bricaire F; Katlama C; Poynard T
    AIDS; 2003 Mar; 17(5):721-5. PubMed ID: 12646795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.